Table 3.
List of miRNAs and their status on clinical trails.
| miRNAs | Details of clinical trails | Reference |
|---|---|---|
| microRNA miR-RX34 (MRX34) | A multicenter phase I study of MRX34, microRNA miR-RX34 to evaluate the safety of MRX34 in patients with primary liver cancer or other selected solid tumors or hematologic malignancies | (26, 27, 10) |
| miRNAs panel | The use of a miRNAs panel to identify thyroid malignancy in FNA leftover cells and the effect of these miRNAs on target genes | (111) |
| miRNA 200 | microRNAs (miRNAs) consisting of 6 miRNA (miRNA-21, miRNA-20a–5p, miRNA-103a–3p, miRNA-106b–5p, miRNA-143–5p, and miRNA-215) was found effective to identify whether one should accept adjuvant chemotherapy or not | (112) |
| miRNAs panel | Plasma microRNA profiling as first line screening test for lung cancer detection: a prospective study | (113) |
| miRNAs panel | A perspective study of the predictive value of microRNA in patients with HER2 positive advanced stage breast cancer who were treated with herceptin | (114) |
| miRNA-29b | The role of microRNA-29b in the oral squamous cell carcinoma | (115) |
| Circulating miRNAs | Circulating miRNAs: novel breast cancer biomarkers and their use for guiding and monitoring response to chemotherapy | (116) |
| miRNA-10b | Evaluating the expression levels of microRNA-10b in patients with gliomas | (117) |